Post Profile






Researchers hope antibody studies will pave way for HIV vaccine

The path for a cure or vaccine for HIV is littered with disappointments – much-hyped treatments or trials have ultimately ended in failure. Today, however, the HIV research community is more hopeful, especially in lieu of PrEP – pre-exposure prophylaxis – the use of the antiretroviral drug Truvada...
read more

share

Related Posts


Researchers believe they may be a step closer to HIV vaccine

Health : The Chart

Researchers are hoping they are one step closer to a HIV vaccine – using HIV. At the 6th International AIDS Society Conference on HIV Pathogens, Treatment, and Prevention in Rome, researchers with the Maryland-based VirxSys Corporat...

False hope from ‘cure’ of Mississippi baby with HIV leads to reinfection of second child

Health : The Checkup

Disappointed researchers reported on Thursday that a second child thought to have been cured of HIV is showing signs of infection. The patient, a boy born born at a hospital in Milan in December 2009, had only stopped treatment for ...

Study of antibody evolution charts course toward HIV vaccine

Health : Medical News Today

In an advance for HIV vaccine research, a scientific team has discovered how the immune system makes a powerful antibody that blocks HIV infection of cells by targeting a site on the virus called V1V2. Many researchers believe that ...

Three Key Approaches to Increasing Research Antibody Validation Defined at GBSI Workshop

Health : Newswise Medical News

Leading experts from the international biomedical research community announced today that they have the fundamentals of what will become the first detailed standardized guidelines for validating research antibodies. The outcomes of ...

Breakthrough Study of HIV in Macaques Confirms Clinically Viable Vaccine Paving the Way for Future Treatment for Humans

Health : Newswise Medical News

In the study, researchers worked with a species of Old World monkeys, rhesus macaques to reproduce the trial results of RV144, the only HIV vaccine that has been tested and shown to reduce the rate of HIV acquisition in a phase III ...

Comments


Copyright © 2016 Regator, LLC